By Cocer Peptides 
1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
1. Overview
Autism Spectrum Disorder (ASD) is a group of neurodevelopmental disorders characterized by deficits in social communication and interaction, as well as repetitive and restrictive behaviors and interests. Oxytocin, a neuropeptide that plays a crucial role in regulating social behavior, has emerged as a potential candidate drug for autism treatment. This article will explore the role and applications of oxytocin in autism treatment.
Figure 1. Regulation of oxytocin and serotonin on autism spectrum disorder (ASD) core symptoms.
2. Biological Basis of Oxytocin
2.1 Structure and Synthesis
Oxytocin (OXT) is a cyclic nonapeptide in which two cysteine amino acids form an intramolecular disulfide bond. It is produced by the hypothalamus and secreted into the bloodstream from the posterior pituitary gland. In the central nervous system, oxytocin-producing neurons are primarily concentrated in the paraventricular nucleus and supraoptic nucleus of the hypothalamus. These neurons project axons to the posterior pituitary gland and other brain regions, such as the amygdala, hippocampus, and prefrontal cortex, thereby regulating various physiological and behavioral functions.
2.2 Mechanism of Action
Oxytocin exerts its effects by binding to specific oxytocin receptors (OXTR). OXTR belongs to the G protein-coupled receptor family and is widely distributed throughout the central nervous system and peripheral tissues. In the brain, activation of OXTR can regulate the release of neurotransmitters such as dopamine and serotonin, thereby influencing neuronal excitability and synaptic plasticity. In the amygdala, oxytocin can regulate the response of amygdala neurons to social stimuli, affecting an individual's processing of emotional information and social cognitive abilities.
3. The Role of Oxytocin in Autism Treatment
3.1 Effects on Social Function
3.1.1 Enhanced Social Interaction
Multiple studies suggest that oxytocin may help improve social interaction in individuals with autism. In a study where adult mice were administered oxytocin (0.8 IU/kg) intranasally daily, the treated animals spent twice as much time interacting with social partners after just two weeks. In human studies, while some clinical trial results vary, certain studies have shown positive effects. For example, a study using oxytocin (24 IU every two days for six weeks) in children with autism found statistically significant improvements in scores on the Social Responsiveness Scale (SRS), indicating enhanced social functioning.
3.1.2 Improved Social Cognition
Oxytocin may influence how individuals with autism recognize and understand social cues. In functional magnetic resonance imaging (fMRI) studies, adult male participants with autism showed a reliable increase in brain activity in the posterior superior temporal gyrus (pSTS) when processing point-light biological motion to identify emotional states following a single dose of intranasal oxytocin (IN-OT). This suggests that oxytocin may enhance the perception and processing of social cues in individuals with autism.
3.2 Effects on Emotional Processing
3.2.1 Regulation of Amygdala Activity
The amygdala plays a critical role in emotional processing and social behavior. Multiple doses of intranasal oxytocin treatment (4 weeks, 24 IU daily) resulted in sustained reduction in brain activity in the bilateral amygdala, which persisted even after the actual treatment period, lasting up to 4 weeks and 1 year post-treatment. Additionally, participants with more pronounced reductions in amygdala activity showed greater behavioral improvements, particularly in self-perceived avoidant attachment and social functioning. This suggests that oxytocin may improve emotional processing and social behavior in individuals with autism by regulating amygdala activity.
3.2.2 Enhanced Emotional Recognition Ability
Some studies indicate that oxytocin may help individuals with autism better recognize emotions. Behavioral experiments involving tasks such as facial expression recognition found that oxytocin administration improved the accuracy of emotional recognition in participants.
3.3 Effects on Repetitive and Stereotyped Behaviors
Some studies suggest that oxytocin may have a beneficial effect on repetitive and stereotyped behaviors in individuals with autism. In a study of adult mice, after four weeks of oxytocin treatment, repetitive behaviors decreased by 30%, and this effect persisted for four weeks after treatment cessation. In human studies, the use of oxytocin (24 IU every two days for six weeks) in children with autism resulted in statistically significant improvements in Repetitive Behavior Scale – Revised (RBS) scores, suggesting a reduction in repetitive and stereotyped behaviors.
4. Application of Oxytocin in Autism Treatment
Clinical Research Progress
Single-Dose Studies
Many randomized controlled trials (RCTs) have investigated the effects of single-dose oxytocin. Numerous studies involving both neurotypical and autistic individuals have shown that single-dose oxytocin administration yields significant beneficial effects compared to placebo. In some studies, single-dose intranasal oxytocin improved performance in specific social tasks among autistic patients, such as increased eye contact and heightened attention to social stimuli.
Multi-dose Long-Term Studies
The results of studies on the long-term use of oxytocin at multiple doses are somewhat inconsistent. Some studies have shown positive effects. In a study of children with autism, four weeks of chronic oxytocin administration (12 IU twice daily) stimulated the endogenous oxytocin system, as evidenced by a significant increase in salivary oxytocin levels 24 hours after the last intranasal spray administration. Additionally, reduced DNA methylation of the oxytocin receptor gene (OXTR) was observed, suggesting increased receptor expression, and was associated with improved feelings of security. In a 24-week placebo-controlled Phase 2 trial, children and adolescents with autism aged 3–17 years were administered 48 international units of intranasal oxytocin daily. The results showed no significant difference between the oxytocin group and the placebo group in the primary outcome measure, the Abnormal Behavior Checklist Modified Social Withdrawal Subscale (ABC-mSW) score.
5. Conclusion
The hormone oxytocin has demonstrated a certain role in the treatment of autism, potentially exerting positive effects on social functioning, emotional processing, and repetitive stereotyped behaviors in individuals with autism.
Sources
[1] Szabó J, Mlynár M, Feješ A, et al. Intranasal oxytocin in a genetic animal model of autism[J]. Molecular Psychiatry, 2024,29(2):342-347.DOI:10.1038/s41380-023-02330-6.
[2] Moerkerke M, Daniels N, Tibermont L, et al. Chronic oxytocin administration stimulates the oxytocinergic system in children with autism[J]. Nature Communications, 2024,15(1):58.DOI:10.1038/s41467-023-44334-4.
[3] Hu L, Du X, Jiang Z, et al. Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis[J]. European Journal of Clinical Pharmacology, 2023,79(10):1357-1363.DOI:10.1007/s00228-023-03545-w.
[4] Sikich L, Kolevzon A, King B H, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder[J]. New England Journal of Medicine, 2021,385(16):1462-1473.DOI:10.1056/NEJMoa2103583.
[5] Tanaka A, Furubayashi T, Arai M, et al. Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.[J]. Molecular Pharmaceutics, 2018,15 3:1105-1111.
[6] Agarikano O P N. Oxytocin in animal models of autism spectrum disorder[J]. Developmental Neurobiology, 2017,77. https://api.semanticscholar.org/CorpusID:44632900
[7] Munesue T, Minabe Y. [The Possible Role of Oxytocin in Autism Spectrum Disorder].[J]. Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica, 2016,118 6:399-409.
[8] Zhao F, Zhang H, Wang P, et al. Oxytocin and serotonin in the modulation of neural function: Neurobiological underpinnings of autism-related behavior[J]. Frontiers in Neuroscience,Volume 16 - 2022.
Product available for research use only:
